Active Pharmaceuticals Ingradients
Pharma ingredients on display at INPHEX exhibition.
INPHEX 2019 is an exhibition that is scheduled to be organized in Saudi Arabia from 24th to 26th February 2019. This event aims at bringing together key players and exhibitors hailing from different segments in the Pharma industry, across as many as 15 nations.
Among multiple exhibition categories, the one for ‘Active Pharma Ingredients’ will also see a lot of participants. In this exhibition category, manufacturers and traders of active pharmaceutical ingredients can participate to cultivate better knowledge concerning the field and escalate their respective business promotion.
First and foremost, Why Saudi Arabia?
Saudi Arabia is needed to focus on one desires to start and expand pharmacy business in the Arab world. Saudi Arabia is the largest country, economy and possesses the biggest market scope for any sorts of pharmaceutical products/equipment/services. API Exhibition Middle East can generate immense business scopes and market opportunities in the country.
Saudi Arabia is a member of WTO! The Saudi government is in favor of improving the healthcare sector in the country and pharmaceutical industry constitutes an integral part of the healthcare sector globally. Several rewarding tax laws, free trade agreements and healthcare reforms received positive response to help local manufacturers & traders as well as invite foreign investment.
Active Pharmaceutical Ingredient
The active pharmaceutical ingredients (API) constitute the part of any drug that is directly responsible for producing effects and treating the health concern. Traditionally, the production of APIs has been done by the pharmaceutical companies on their own in the country.
Recently, Saudi Arabia (like many other nations) has started outsourcing manufacturing overseas to cut expenditure on costly tools, skilled labor, and infrastructure. The local drug manufacturing companies no longer stay busy with every step of the drug-making process, including API creation. This trend has significantly influenced the way the drugs are regulated. Now, more rigorous guidelines and inspections are ensured before they are circulated in the market by the active pharmaceutical ingredient manufacturers. The quality of APIs has a prominent effect on the safety and efficacy of medications so buying the APIs from a reliable overseas company is very crucial. This stringent regulatory framework has made the API market a complex one.
The Global Active Pharmaceutical Ingredients (API) market is believed to receive a boost from around $129.12 billion in 2015 to $198.8 billion by 2022 with a CAGR reading 6.4%. The factors that are fueling this growth in full throttle can be-
Patent expiration of popular drugs
Technological progress in API manufacturing
The popular use of Biopharmaceuticals
An inclination to Generic Drugs
Active pharmaceutical ingredient manufacturers globally opine that there has been a recent shift in demand towards Generic drugs. With the patent expiration of innovative drug, their easy availability in the market make them popular. The demand to produce quality medicines at an affordable price value also favors its growth.
Now, why INPHEX?
➔ If participated and the opportunity is used intelligently, this gathering
might serve as a breeding ground for advantageous business contacts.
➔ Information on methodologies, technology, research work, patent rights
and as such can be availed at INPHEX because it will be participated by
hundreds from the same field.
➔ Seminars covering relevant topics will help to get a deeper insight into
the recent trends & innovations practiced in API sector.